Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neuropathogenesis

Redox Report

Volumn 5, Issue 2-3, 2000, Pages 108-111

  Guillemin, G J ^a   Smith, D G ^a   Kerr, S J ^a   Smythe, G A ^b   Kapoor, V ^b   Armati, P J ^c   Brew, B J ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 6; KYNURENIC ACID; KYNURENINE; NEUROTOXIN; QUINOLINIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ASTROCYTE; CELL METABOLISM; CELL STIMULATION; CONTROLLED STUDY; DEGRADATION; ENZYME ASSAY; FETUS; HUMAN; HUMAN CELL; MACROPHAGE; MICROGLIA; NEUROPATHOLOGY; NEUROPROTECTION; NEUROTOXICITY; PRIORITY JOURNAL; TOXIN SYNTHESIS;

EID: 0033928598     PISSN: 13510002     EISSN: None     Source Type: Journal    
DOI: 10.1179/135100000101535375     Document Type: Article

References (10)

1. Neuropharmacology of quinolinic and kynurenic acids
2. Brain tryptophan
3. Chemistry and neurochemistry of the kynurenine pathway of tryptophan metabolism
4. Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types
5. Kynurenine pathway inhibition reduces toxicity of HIV- infected macrophages
6. Kynurenine amino- transferase I (KATI) isoform gene expression in the rat brain: An in situ hybridization study
7. Obtention and characterization of astrocytes and microglia from adult monkey brains
8. Kynurenine pathway inhibition reduces toxicity of HIV-infected macrophages_rfsti Neurology
9. Kynurenic acid, an endogenous glutamate antagonist, in SHR and WKY rats: Possible role in central blood pressure regulation
10. How HIV leads to neurological disease